Chemical Compound

mitoxantrone

CAS Registry Number 65271-80-9
Back to search Request a Quote
mitoxantrone chemical structure
Primary Record

mitoxantrone

In stock
8,811 g
Purity
99.8 %
CAS
65271-80-9

Compound Identifiers & Properties

CAS
65271-80-9
PubChem CID
4212
SMILES
C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
Canonical SMILES
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21

Names & Synonyms

  • mitoxantrone
  • Mitozantrone
  • Mitoxanthrone
  • Mitoxantron
  • Mitoxantrona
  • DHAQ
  • Dihydroxyanthraquinone
  • Mitoxantronum
  • Novantrone
  • Novantron
  • 65271-80-9
  • Misostol
  • Mitox
  • Mitoxantrone-d8
  • nimitoxantron
  • Mitoxantrone [INN]
  • Mitoxantrone HCl
  • Ralenova
  • Dhaq diacetate
  • Ovex
  • Mitoxantrone 2HCl
  • DHAD
  • Misostol (TN)
  • Mitoxantrone base
  • 2fum
  • Mitoxantrone hydrochloride
  • Mitoxantrone (INN)
  • Mitoxantronum [INN-Latin]
  • Novantrone (TN)
  • Mitoxantrona [INN-Spanish]
  • DHAQ HCl
  • Mitoxantrone free base
  • Acetate, Mitoxantrone
  • Immunex (Salt/Mix)
  • Mitoxantrone diacetate
  • Mitoxantrone dihydrochloride
  • dihydroxyanthracenedione
  • Mitozantrone hydrochloride
  • Mitoxantrone (free base)
  • Mitoxantrone [INN:BAN]
  • BZ114NVM5P
  • Spectrum_001655
  • Mitoxantrone (Standard)
  • RefChem:55656
  • UNII-BZ114NVM5P
  • NSC-279836
  • DHAQ (*Diacetate salt*)
  • mitoyantrone hydrochloride
  • AC1L1HNY
  • CHEMBL58
  • Prestwick0_000385
  • Prestwick1_000385
  • Prestwick2_000385
  • Prestwick3_000385
  • Spectrum2_000908
  • Spectrum3_001590
  • Spectrum4_000866
  • Spectrum5_001205
  • CCRIS 7604
  • Lopac-M-6545
  • MITOXANTRONE [MI]
  • C22H28N4O6
  • D0R3JB
  • MITOXANTRONE [IARC]
  • cid_4212
  • MLS002703044
  • Neuro_000153
  • SCHEMBL3000
  • KKZJGLLVHKMTCM-UHFFFAOYSA-N
  • NSC 279836
  • MITOXANTRONE [VANDF]
  • BIDD:PXR0181
  • Lopac0_000779
  • MFCD00242942
  • NSC279836
  • BSPBio_000569
  • BSPBio_003160
  • DTXSID4046947
  • KBioGR_001531
  • KBioSS_002135
  • CHEBI:50729
  • MLS001333711
  • DivK1c_000516
  • MITOXANTRONE [WHO-DD]
  • SPBio_000756
  • SPBio_002490
  • BPBio1_000627
  • GTPL7242
  • orb1300634
  • 65271-80-9 (free base)
  • DTXCID2026947
  • SCHEMBL29353270
  • SCHEMBL29720597
  • BDBM67690
  • cid_5458171
  • CTK8A5416
  • KBio1_000516
  • KBio2_002135
  • KBio2_004703
  • KBio2_007271
  • KBio3_002660
  • BRN 2795126
  • CID4212
  • L01DB07
  • MITOXANTHRONE HYDROCHLORIDE
  • NINDS_000516
  • NSC299195
  • GLXC-03038
  • HMS2090D05
  • HMS3655E20
  • KUC108634N
  • NSC301739D
  • BCP02861
  • EBD32557
  • NSC 301739D
  • NSC-301739D
  • ZINC3794794
  • CCG-36371
  • CM0184
  • EBC-17113
  • HY-13502R
  • NSC287836
  • NSC301739
  • s1889
  • STK631833
  • C22H28N4O6.2C2H4O2
  • Liposome Encapsulated Mitoxantrone (LEM)
  • Mitoxantrone hydrochloride (Salt/Mix)
  • AKOS005564036
  • C22-H28-N4-O6
  • BCP9000931
  • CS-2524
  • DB01204
  • FD26022
  • KSC-19-204
  • NSC 287836
  • NSC 299195
  • NSC-287836
  • NSC-299195
  • NSC-301739
  • SDCCGSBI-0050757.P004
  • IDI1_000516
  • SMP2_000179
  • 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
  • NCGC00015693-01
  • NCGC00015693-02
  • NCGC00015693-03
  • NCGC00015693-04
  • NCGC00015693-05
  • NCGC00015693-06
  • NCGC00015693-08
  • NCGC00015693-13
  • NCGC00015693-21
  • NCGC00015693-23
  • NCGC00162251-01
  • 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone
  • AC-37649
  • AK323601
  • AN-14761
  • AN-38696
  • AS-35321
  • BC651765
  • CL232325
  • HY-13502
  • J19.969I
  • K061
  • LS-20638
  • NCI60_002276
  • NCI60_002535
  • SC-22733
  • SMR000058480
  • SMR001549953
  • SY226320
  • SBI-0050757.P003
  • CAS-70476-82-3
  • CL 232325
  • CL-232315
  • J710.751J
  • TX-017756
  • 2590B
  • AB00053716
  • FT-0630752
  • FT-0672423
  • M3133
  • NS00008439
  • SW196745-6
  • 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon
  • 1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione
  • C22-H28-N4-O6.2C2-H4-O2
  • VU0244399-2
  • 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone
  • 71M809
  • A10595
  • C11195
  • D08224
  • EN300-117257
  • 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
  • 13181-EP2270008A1
  • 13181-EP2270505A1
  • 13181-EP2272827A1
  • 13181-EP2275420A1
  • 13181-EP2277876A1
  • 13181-EP2289892A1
  • 13181-EP2292617A1
  • 13181-EP2295055A2
  • 13181-EP2295412A1
  • 13181-EP2295413A1
  • 13181-EP2295416A2
  • 13181-EP2295426A1
  • 13181-EP2295427A1
  • 13181-EP2298748A2
  • 13181-EP2298764A1
  • 13181-EP2298765A1
  • 13181-EP2301928A1
  • 13181-EP2305642A2
  • 13181-EP2305660A1
  • 13181-EP2311453A1
  • 13181-EP2311808A1
  • 13181-EP2311829A1
  • 13181-EP2311837A1
  • 13181-EP2311840A1
  • 13181-EP2311842A2
  • 13181-EP2316832A1
  • 13181-EP2316833A1
  • 13181-EP2316834A1
  • AB00053716-18
  • AB00053716-19
  • AB00053716-22
  • AB00053716_23
  • AB00053716_24
  • Novantrone(R) (mitoxantrone for injection concentrate)
  • 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
  • 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
  • 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione
  • AN-584/42007670
  • Q239426
  • SR-01000076001
  • A1035790
  • SR-01000076001-7
  • 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione
  • 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione
  • 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-
  • BRD-K21680192-001-01-5
  • BRD-K21680192-001-11-4
  • BRD-K21680192-300-05-2
  • BRD-K21680192-300-07-8
  • BRD-K21680192-300-09-4
  • BRD-K21680192-300-10-2
  • BRD-K21680192-300-12-8
  • BRD-K21680192-300-14-4
  • BRD-K21680192-300-15-1
  • BRD-K21680192-300-16-9
  • 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone
  • 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione
  • ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-
  • B2693-074515
  • MIX
  • 1,32-Dotriacontanediol, 3,7,11,15,18,22,26,30-octamethyl-
  • 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione
  • 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-
  • 1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone
  • 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone
  • 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone
  • 1189974-82-0
  • 9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-
  • MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
  • MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE
  • 1,3-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione
  • 1,4-Bis[[2-[(2-hydroxyethyl)amino]ethyl]imino]-1,4-dihydroanthracene-5,8,9,10-tetrol
  • 1,4-Bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxy-9,10-anthraquinone
  • 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthroquinone
  • 1,4-DIHYDROXY-5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-9,10-ANTHRACENEDIONE
  • 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione diacetate
  • 1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone
  • 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride
  • 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride
  • 1,4-Dihydroxy-5,8-bis[2-[(2-hydroxyethyl)amino]ethylamino]-9,10-anthraquinone
  • 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone 1,4-diaceate
  • 5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}imino)-5,8-dihydroanthracene-1,4,9,10-tetrol
  • 5,8-Dihydroxy-1,4-bis(5-hydroxy-3-azapentane-1-ylamino)anthracene-9,10-dione
  • 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-(9CI)
  • 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride
  • 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9,10-dihydroanthracene-9,10-dione
  • 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxy-9,10-anthracenedione diacetate
  • 65271-89-8
  • 70711-41-0
  • 833-758-3
  • 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-; 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione; 1,4-Bis[(2-(2-hydroxyethylamino)ethyl)amino]-5,8-dihydroxyanthraquinone; 1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone; DHAQ; Dihydroxyanthraquinone; Mitox; Mitoxanthrone; Mitoxantrone; Mitozantrone; NSC 279836; Nimitoxantron; Novantron; Novantrone; Ralenova
  • Anthraquinone, 5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxy-, 1,4-diacetate (salt)
  • MITOXANTRONE; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
  • Mitozantrone|||Novantron|||CL-232325|||1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione